Catalyst-controlled C–H allylation and annulation of quinazolinones with 2-methylidene cyclic carbonate
The site-selective modification of quinazolinone as a privileged bicyclic N-heterocycle is an attractive topic in medicinal chemistry and material science. We herein report the ruthenium(II)-catalyzed C–H allylation of 2-aryl quinazolinones with 2-methylidene cyclic carbonate. In addition, tandem C–H allylation and annulation are achieved under rhodium(III) catalysis, resulting in the formation of tetracyclic quinazolinones including a tertiary carbon center. Post-transformations of the synthesized products demonstrate the potential of the developed methodology. A series of mechanistic investigations were also performed.
2024 Spring Convention